ea0038p64 | Clinical practice/governance and case reports | SFEBES2015
Clay Caroline
, Ho Jan Hoong
, Severn Maia
, Kaushal Kalpana
, Howell Simon
Case 1: A 65-year-old man was admitted with symptomatic hypocalcaemia (corrected calcium of 1.65 mmol/l, PTH 46.6 (1.66.8) pmol/l, and vitamin D 51.4 (50150) nmol/l)) 5 days following denosumab initiation. He had a diagnosis of probable urothelial carcinoma with associated osteoblastic metastases, and 10 days prior to this admission had been treated for hypercalcaemia (corrected calcium of 3.04 (2.202.60) mmol/l) with i.v. fluids following which denosumab was...